Nono induces Gadd45b to mediate DNA repair.
Victoria MamontovaBarbara TrifaultKaspar BurgerPublished in: Life science alliance (2024)
RNA-binding proteins are frequently deregulated in cancer and emerge as effectors of the DNA damage response (DDR). The non-POU domain-containing octamer-binding protein NONO/p54 nrb is a multifunctional RNA-binding protein that not only modulates the production and processing of mRNA, but also promotes the repair of DNA double-strand breaks (DSBs). Here, we investigate the impact of Nono deletion in the murine KP ( KRas G12D , Trp53 -/- ) cell-based lung cancer model. We show that the deletion of Nono impairs the response to DNA damage induced by the topoisomerase II inhibitor etoposide or the radiomimetic drug bleomycin. Nono-deficient KP (KPN) cells display hyperactivation of DSB signalling and high levels of DSBs. The defects in the DDR are accompanied by reduced RNA polymerase II promoter occupancy, impaired nascent RNA synthesis, and attenuated induction of the DDR factor growth arrest and DNA damage-inducible beta (Gadd45b). Our data characterise Gadd45b as a putative Nono-dependent effector of the DDR and suggest that Nono mediates a genome-protective crosstalk of the DDR with the RNA metabolism via induction of Gadd45b.
Keyphrases
- dna repair
- dna damage
- dna damage response
- binding protein
- oxidative stress
- nucleic acid
- induced apoptosis
- gene expression
- dna methylation
- stem cells
- dendritic cells
- cell therapy
- mesenchymal stem cells
- squamous cell carcinoma
- emergency department
- papillary thyroid
- squamous cell
- electronic health record
- circulating tumor
- adverse drug
- type iii
- deep learning